Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
AIFM2
REST API REST API
Homo sapiens
AIFM2 is differentially expressed in 176 experiments: 91 organism parts: adipose tissue, cerebellum, ... (89 more);, 75 disease states: normal, cervical carcinoma, ... (73 more);, 73 cell types 306 cell lines 27 compound treatments and 50 other conditions.
Synonyms AMID, FLJ14497, PRG3
Orthologs AIFM2 (Gallus gallus)   ENSCING00000001811 (Ciona intestinalis)   Aifm2 (Mus musculus)   AIFM2_BOVIN (Bos taurus)   AIF1 (Saccharomyces cerevisiae)   AIFM2 (Danio rerio)   Aifm2 (Rattus norvegicus)   aifm2 (Xenopus laevis)   AIFM2 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term cytosol, oxidoreductase activity, DNA binding, cytoplasm, membrane, mitochondrial outer membrane, induction of apoptosis, integral to membrane, electron-transferring-flavoprotein dehydrogenase activity, chromosome condensation, mitochondrion, apoptotic mitochondrial changes, oxidation-reduction process, flavin adenine dinucleotide binding
InterPro Term Pyridine_nuc-diS_OxRdtase_2, Rng_hydrolase-like, FAD_pyr_nucl-diS_OxRdtase, Pyr_nucl-diS_OxRdtase_FAD/NAD, Pyr_OxRdtase_NAD-bd_dom
UniProt Accession Q9BRQ8, C9JI05
Search EB-eye ENSG00000042286
Show more properties
Experimental Factors
Organism part

studied in E-AFMX-5, E-GEOD-803, E-GEOD-6573, E-TABM-130, E-GEOD-3526, ... (14 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-3860, E-GEOD-17482, E-GEOD-14464, E-GEOD-19639, E-GEOD-24147, ... (23 experiments)

Factor Value U/D Experiments
A549
2
E-GEOD-3202, E-GEOD-6013
HT1080
2
E-GEOD-20089, E-MTAB-37
LNCaP
2
E-GEOD-14990, E-GEOD-14464
MCF-7
2
E-GEOD-19639, E-GEOD-20081
HCC1954
1
E-MTAB-37
SNU423
1
E-MTAB-37
300 more value(s).


Cell type

studied in E-GEOD-21668, E-GEOD-20677, E-GEOD-4219, E-GEOD-13987, E-TABM-34, ... (30 experiments)

Factor Value U/D Experiments
human embryonic stem cell
1
2
E-GEOD-18265, E-GEOD-20033, E-GEOD-18147
basal cell
1
E-GEOD-3998
dermal fibroblast
1
E-MEXP-1216
B cell
2
1
E-GEOD-13987
lung carcinoma
1
E-GEOD-17347
naive B cell
1
E-TABM-702
67 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-6872, E-GEOD-2508, E-GEOD-15960, E-MEXP-1121, ... (34 experiments)

Factor Value U/D Experiments
normal
6
7
E-GEOD-6338, E-TABM-702, E-GEOD-13987, E-MEXP-561, E-GEOD-5563, ... (13 experiments)
in vitro incubation with E. coli
1
E-MEXP-555
T-cell/histiocyte rich B cell lymphoma
1
E-GEOD-7788
adenocarcinoma
1
E-MTAB-37
plasma cell myeloma
1
E-MTAB-37
Hodgkin lymphoma
1
E-MTAB-37
69 more value(s).


Compound treatment

studied in E-GEOD-5741, E-TABM-868, E-GEOD-15811, E-GEOD-5099, E-MEXP-1958, ... (17 experiments)

Factor Value U/D Experiments
lipopolysaccharide
2
E-MEXP-1958, E-TABM-868
AMP
1
1
E-MEXP-2285
TTA
1
E-MEXP-2590
unknown
1
E-GEOD-7307
no estradiol
1
E-GEOD-20081
5-aza-2'-deoxycytidine
1
1
E-GEOD-5230
21 more value(s).


Age at diagnosis

studied in E-GEOD-3494

Factor Value U/D Experiments
41
2
1
E-GEOD-3494
32
2
1
E-GEOD-3494


Agent
studied in E-GEOD-19519

Biosource provider
studied in E-MTAB-37, E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19519

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19246, E-GEOD-21589, E-GEOD-16363, ... (6 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-20033, E-GEOD-4667

Disease staging
studied in E-GEOD-19743, E-GEOD-22544, E-GEOD-22148, E-GEOD-21887, E-GEOD-19665 ... (5 experiments)

Environmental stress
studied in E-GEOD-1643

Estrogen receptor status
studied in E-GEOD-6532

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-GEOD-7578, E-GEOD-17385, E-GEOD-20847, ... (8 experiments)

Genotype
studied in E-TABM-763, E-GEOD-17476, E-TABM-868, E-TABM-601, E-GEOD-17347 ... (5 experiments)

Gestation age
studied in E-GEOD-14334

Growth condition
studied in E-GEOD-13073, E-MEXP-2657, E-TABM-127, E-GEOD-20540, E-GEOD-20504, ... (7 experiments)

Histology
studied in E-TABM-234, E-GEOD-20559, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-MEXP-1290, E-MEXP-2069, E-TABM-666, ... (20 experiments)

Infection
studied in E-GEOD-12108, E-GEOD-12254, E-MEXP-561

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-22056

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-GEOD-9171

Media
studied in E-MEXP-765

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

P53 ihc
studied in E-GEOD-21653

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-1657, E-GEOD-17636

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-19445, E-GEOD-19246

Replicate
studied in E-GEOD-18791

RNAi
studied in E-GEOD-3485, E-MEXP-2759

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-17400

Sex
studied in E-GEOD-7307

Stimulation
studied in E-GEOD-20114, E-GEOD-11886, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Treatment
studied in E-GEOD-19246, E-GEOD-13818, E-GEOD-12198

Processing time: 0.326 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM